Jardiance for heart failure: How it works, effectiveness & more
The Checkup by Singlecare
MARCH 21, 2024
The drug and its fellow SGLT2 inhibitors, Farxiga (dapagliflozin), Invokana (canagliflozin), Steglatro (ertugliflozin), and Brenzavvy (bexagliflozin), are approved by the Food and Drug Administration (FDA) for treatment of Type 2 diabetes. But unlike the other drugs, Jardiance has evidence to support its different uses.
Let's personalize your content